A British pharmaceutical giant is already manufacturing its unproven coronavirus vaccine as it hopes to dish out hundreds of millions of doses by September. AstraZeneca has started to mass-produce its AZD1222 jab, being developed by Oxford University, at factories in India, Oxford, Switzerland and Norway. The Cambridge-based firm expects to have made and distributed hundreds of millions … Read more
British people will be able to access a coronavirus vaccine from September, the chief executive of drug maker AstraZeneca has said, despite concerns it will not be ready. Pascal Soriot told The Andrew Marr Show on Sunday that British people will get first access to the vaccine from autumn. The pharmaceutical firm, which is working … Read more
Pharmaceutical giant AstraZeneca strikes deal with Oxford University to mass produce experimental COVID-19 vaccine with first results from human trials expected in June The agreement was announced this morning, with the details set to be finalised It will allow for rapid vaccination around the world, if the jab is proven to work And it will … Read more
Drugs giant AstraZeneca in talks with governments to find cure for virus Research agreements could be announced in the coming days A deal would see the company team up with experts on monoclonal antibodies By Jamie Nimmo For The Financial Mail On Sunday Published: 23:05 GMT, 21 March 2020 | Updated: 23:05 GMT, 21 March … Read more
IN THE MONEY: AstraZeneca boss Pascal Soriot to get £7m in shares if he hits his targets By Daily Mail City & Finance Reporter Published: 22:44 GMT, 10 March 2020 | Updated: 22:44 GMT, 10 March 2020 Astrazeneca boss Pascal Soriot has been granted more than £7million worth of shares. The 60-year-old, who has been … Read more